Novel mutations in B3GALNT2 gene causing α-dystroglycanopathy in Chinese patients
Xiao-Yu Chen,Dan-Yu Song,Yan-Bin Fan,Dan-Dan Tan,Xing-Zhi Chang,Jiang-Xi Xiao,Tatsushi Toda,Hui Xiong
DOI: https://doi.org/10.1097/cm9.0000000000001283
IF: 6.133
2020-12-07
Chinese Medical Journal
Abstract:Alpha-dystroglycanopathy (α-DGP) is a subtype of congenital muscular dystrophies (CMDs) with autosomal recessive inheritance. Its main pathogenesis is the defect of post-translational O-glycosylation in α-dystroglycan (α-DG). α-DGP presents a wide clinical spectrum that ranges from the most severe CMDs such as Walker-Warburg syndrome (WWS), muscle-eye-brain disease (MEB), and Fukuyama congenital muscular dystrophy to the mildest limb-girdle muscular dystrophy. The <em>B3GALNT2</em> (NM 152490) is one of the pathogenic genes of α-DGP. It encodes an enzyme that produces a unique carbohydrate structure, nitroacetylgalactosamine-β-1,3-nitroacetylglucosamine (GalNAc-β-1–3GlcNAc), which is essential for O-glycosylation of α-DG.<sup><a class="ejp-citation-link js-ejp-citation-link">[1]</a></sup> Most patients with <em>B3GALNT2</em> mutations in previous studies presented with the most severe WWS or less severe MEB<sup><a class="ejp-citation-link js-ejp-citation-link">[2]</a></sup> and those with WWS generally had a very short lifespan. They universally exhibited severe muscle weakness, ocular anomalies, including congenital cataract, glaucoma, severe myopia, and optic nerve atrophy. Their brain imaging showed cobblestone lissencephaly or polymicrogyria, cerebellum cysts, and dysplasia.
medicine, general & internal